GT

Guided Therapeutics IncOOTC GTHP Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Nov, 2024

Last price

Market cap $B

0.009

Micro

Exchange

OOTC - OTC

GTHP Stock Analysis

GT

Uncovered

Guided Therapeutics Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-42/100

Low score

Market cap $B

0.009

Dividend yield

Shares outstanding

48.919 B

Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. The company is headquartered in Norcross, Georgia. The firm is focused on selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. The firm focuses on two primary applications for LuViva as a cancer screening tool, and triage traditional screening. Screening is for cervical cancer represents the practice of diagnostic medicine. The firm is also focused on the extension of its cancer detection technology into other cancers, including esophageal.

View Section: Eyestock Rating